These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 26231702)

  • 1. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
    Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
    J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis.
    Ebrahimpour A; Ahir M; Wang M; Jegga AG; Bonnen MD; Eissa NT; Montesi SB; Raghu G; Ghebre YT
    Sci Rep; 2022 Nov; 12(1):20668. PubMed ID: 36450789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway.
    Ebrahimpour A; Wang M; Li L; Jegga AG; Bonnen MD; Eissa NT; Raghu G; Jyothula S; Kheradmand F; Hanania NA; Rosas IO; Ghebre YT
    J Inflamm (Lond); 2021 May; 18(1):17. PubMed ID: 34011367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.
    Ghebre YT; Raghu G
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1345-52. PubMed ID: 27110898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model.
    Nelson C; Lee J; Ko K; Sikora AG; Bonnen MD; Enkhbaatar P; Ghebre YT
    Front Pharmacol; 2017; 8():16. PubMed ID: 28184197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors in IPF: beyond mere suppression of gastric acidity.
    Ghebre Y; Raghu G
    QJM; 2016 Sep; 109(9):577-579. PubMed ID: 27647940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
    Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
    J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.
    Ahluwalia N; Grasberger PE; Mugo BM; Feghali-Bostwick C; Pardo A; Selman M; Lagares D; Tager AM
    Am J Respir Cell Mol Biol; 2016 Jun; 54(6):831-42. PubMed ID: 26600305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
    Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
    Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.
    Smith MR; Gangireddy SR; Narala VR; Hogaboam CM; Standiford TJ; Christensen PJ; Kondapi AK; Reddy RC
    Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L616-25. PubMed ID: 20061443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
    Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC
    Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibition of α
    Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
    Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
    Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
    Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
    Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis.
    Lambers C; Boehm PM; Karabacak Y; Samaha E; Benazzo A; Jaksch P; Roth M
    Biomed Res Int; 2019; 2019():1345402. PubMed ID: 30984775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected].
    Krempaska K; Barnowski S; Gavini J; Hobi N; Ebener S; Simillion C; Stokes A; Schliep R; Knudsen L; Geiser TK; Funke-Chambour M
    Respir Res; 2020 Jan; 21(1):25. PubMed ID: 31941499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenite selectively kills lung fibroblasts to treat bleomycin-induced pulmonary fibrosis.
    Lin JH; Liu CC; Liu CY; Hsu TW; Yeh YC; How CK; Hsu HS; Hung SC
    Redox Biol; 2024 Jun; 72():103148. PubMed ID: 38603946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.